WHO maps global needlesafe needs
This article was originally published in Clinica
With unsafe injections causing an estimated 1.3 million early deaths and costing the world's health systems some $535 million in direct medical costs every year, there is huge scope for manufacturers of needlesafe technologies to harness a major global need. The World Health Organization (WHO) is renewing calls for policies to widen access to safe and disposable injection equipment and to cut the number of unnecessary injections.
You may also be interested in...
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.
India’s Hilleman Laboratories says it’s aiming to develop an affordable vaccine that will target pregnant women in low- and middle-income countries to prevent Group B Streptococcus, a potentially fatal infection passed to babies during childbirth.
Chi-Med’s surufatinib has come up trumps in a second trial in neuroendocrine tumors, after the monitoring committee recommended an early halt following achievement of its PFS target in the pancreatic setting.